Bill Sibold, Madrigal Pharmaceuticals CEO , joins 'Fast Money' to talk quarterly results.

Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

Madrigal Pharmaceuticals ... reducing the time from prescription to first dose. This could lead to faster initiation of treatment for patients and potentially increase the number of patients ...

From STAT’s Matthew Herper: Eikon Therapeutics, the cell-biology-focused startup run by former Merck R&D head Roger ...

Welcome to Madrigal Pharmaceuticals' Fourth Quarter ... it's easy to take, it works fast, and the results that we're seeing in the real world are extremely promising. So, what we believe is ...

Madrigal Pharmaceuticals, Inc. (NASDAQ ... reducing the time from prescription to first dose. This could lead to faster initiation of treatment for patients and potentially increase the number of ...

Madrigal Pharmaceuticals MDGL reported fourth ... This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting ...

Dave Racaniello is entering his 25th year as New York’s bullpen catcher thanks to a chance meeting with Bobby Valentine.

A trial date is scheduled in April for a man authorities say was impaired by alcohol and marijuana when his SUV plowed into a ...